-
Midland signs option deal with Barrick for Lewis gold property
-
MEDNAX (MD) Tops Q3 EPS by 20c ; Provides Outlook
-
Pediatrix Medical Group (MD) PT Raised to $17 at Leerink Partners
-
Pediatrix Medical Group (MD) PT Raised to $16.50 at UBS
-
Pediatrix Medical Group (MD) PT Lowered to $19 at Jefferies
-
MEDNAX (MD) Tops Q2 EPS by 11c; updates guidance
-
Midland raises $6.1M with Centerra Gold taking 9.9% stake
-
Pediatrix Medical (MD) adds Kurt Newman to Board
-
MEDNAX (MD) Tops Q1 EPS by 9c; raises guidance
-
Pediatrix Medical Group (MD) PT Raised to $18 at Mizuho
-
Pediatrix Medical Group (MD) PT Raised to $18 at Mizuho
-
MEDNAX (MD) Tops Q4 EPS by 14c ; Provides Outlook
-
Macquarie Starts Pediatrix Medical Group (MD) at Outperform
-
MEDNAX (MD) Misses Q3 EPS by 14c
-
Jefferies Upgrades Pediatrix Medical Group (MD) to Buy
-
Pediatrix Medical Group (MD) PT Raised to $10 at Truist Securities
-
MEDNAX (MD) Tops Q2 EPS by 3c
-
These stocks offer you exposure to rising demand for fertility treatment – Barclays

